ERBB2 and neoplasm: Investigational studies utilising positron emission tomography and scintigraphy have shown that it is possible to detect HER2 and ER in vivo (Linden et al, 2006; Perik et al, 2006), and an increased need to visualise these tumour targets is apparent as targeted therapies against specific molecules in cancer are rapidly developing.